Overview

A Phase 1b Study to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Doses of JNJ-64565111 in Participants With Type 2 Diabetes Mellitus

Status:
Completed
Trial end date:
2018-02-19
Target enrollment:
Participant gender:
Summary
The purpose of this Phase 1b study is to assess the safety and tolerability of JNJ-64565111 in adult men and women (of non-child bearing potential) with Type 2 Diabetes Mellitus.
Phase:
Phase 1
Details
Lead Sponsor:
Janssen Research & Development, LLC